NurExone Biologic Inc.
NRXBF
$0.40
$0.000.40%
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 156.80% | 205.43% | -61.04% | -48.51% | -81.94% |
| Total Receivables | 13.33% | -29.92% | -52.90% | -76.54% | -65.38% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -42.77% | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.32% | 580.49% | 0.00% | 0.00% | 28.13% |
| Total Current Assets | 25.15% | 59.18% | -59.40% | -29.85% | -62.90% |
|
|
|||||
| Total Current Assets | 25.15% | 59.18% | -59.40% | -29.85% | -62.90% |
| Net Property, Plant & Equipment | 5.93% | 7.06% | 11.50% | 79.33% | 66.88% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 47.06% | 67.27% | -26.78% | -13.00% | -48.33% |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 142.78% | 103.54% | 112.79% | 90.17% | -19.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | 1,800.00% | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -15.30% | 357.89% | 88.59% | 81.77% | 179.39% |
| Total Other Current Liabilities | -15.30% | 357.89% | 88.59% | 81.77% | 179.39% |
| Total Current Liabilities | 38.16% | 148.49% | 98.16% | 84.43% | 52.76% |
|
|
|||||
| Total Current Liabilities | 38.16% | 148.49% | 98.16% | 84.43% | 52.76% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 119.35% | 125.81% | 154.84% | 264.00% | 29.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 30.42% | 5.98% | 12.73% | 60.27% | 92.00% |
| Total Liabilities | 38.96% | 94.85% | 73.32% | 85.77% | 61.25% |
|
|
|||||
| Common Stock & APIC | 31.21% | 34.04% | 33.97% | 35.21% | 23.74% |
| Retained Earnings | -31.15% | -33.42% | -37.23% | -38.76% | -38.71% |
| Treasury Stock & Other | 46.88% | 54.12% | -36.16% | -31.59% | -20.44% |
| Total Common Equity | 52.13% | 56.62% | -50.24% | -40.50% | -63.76% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 52.13% | 56.62% | -50.24% | -40.50% | -63.76% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 52.13% | 56.62% | -50.24% | -40.50% | -63.76% |
|
|
|||||